Bausch Health Announces 2021 Annual Meeting of Shareholder Results
Bausch Health Companies Inc. (NYSE/TSX: BHC) announced the successful election of 13 nominated directors at its annual meeting on April 27, 2021. Among the elected were Richard U. De Schutter and Sarah B. Kavanagh, receiving over 200 million votes for their positions. Shareholders also approved the compensation of named executive officers in a non-binding advisory vote and appointed PricewaterhouseCoopers LLP as the independent public accounting firm until the 2022 meeting. Full vote details will be reported to the SEC.
- Successful election of all 13 nominated directors with significant support, indicating strong shareholder confidence.
- Shareholders approved executive compensation, reflecting continued trust in leadership.
- None.
LAVAL, Quebec, April 28, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the election of the 13 directors nominated at its 2021 annual meeting of shareholders held on April 27, 2021. The detailed results of the vote for the election of directors are set out below:
Name | For | Withheld | Broker Non-Votes |
Richard U. De Schutter | 200,369,606 | 5,768,489 | 60,380,196 |
D. Robert Hale | 196,356,636 | 9,781,459 | 60,380,196 |
Brett Icahn | 196,491,749 | 9,646,346 | 60,380,196 |
Dr. Argeris (Jerry) N. Karabelas | 198,928,372 | 7,209,723 | 60,380,196 |
Sarah B. Kavanagh | 203,110,562 | 3,027,533 | 60,380,196 |
Steven D. Miller | 200,857,243 | 5,280,852 | 60,380,196 |
Joseph C. Papa | 198,455,884 | 7,682,211 | 60,380,196 |
John A. Paulson | 205,191,567 | 946,528 | 60,380,196 |
Robert N. Power | 177,088,588 | 29,049,507 | 60,380,196 |
Russel C. Robertson | 197,810,980 | 8,327,115 | 60,380,196 |
Thomas W. Ross, Sr. | 186,746,866 | 19,391,229 | 60,380,196 |
Andrew C. von Eschenbach, M.D. | 205,016,196 | 1,121,899 | 60,380,196 |
Amy B. Wechsler, M.D. | 200,266,488 | 5,871,607 | 60,380,196 |
At the annual meeting of shareholders, shareholders also approved in a non-binding advisory vote the compensation of the Company's named executive officers and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2022 annual meeting of shareholders.
The final vote tabulation on all matters voted on at the meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's website at www.bauschhealth.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(514) 856-3855 | (908) 927-1198 |
(877) 281-6642 (toll free) |
View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-2021-annual-meeting-of-shareholder-results-301278480.html
SOURCE Bausch Health Companies Inc.
FAQ
What were the results of the Bausch Health annual meeting held on April 27, 2021?
Who were the elected directors of Bausch Health in 2021?
What was approved in the Bausch Health shareholders meeting regarding executive compensation?
Which firm was appointed as Bausch Health's public accounting firm in 2021?
Where can I find the detailed results of the Bausch Health annual meeting?
